Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Mississippi?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. A Mississippi resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a physician or physician assistant with an unrestricted Mississippi license, including by telemedicine under the Board of Medical Licensure's telemedicine rule (Miss. Admin. Code Title 30, Part 2635, Chapter 5), which requires an unrestricted Mississippi license, a valid physician-patient relationship, and a real-time interaction with the provider. A questionnaire alone is not enough. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy permitted by the Mississippi Board of Pharmacy; out-of-state pharmacies need a nonresident permit under Miss. Code section 73-21-106 and must use a pharmacist-in-charge who also holds a Mississippi pharmacist license. The Board has issued guidance rejecting compounded semaglutide made from salt forms.

Regulatory: Telehealth allowedRegulatory: Async not allowedRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous not allowed; a questionnaire alone is not enough
Compounded GLP-1
Limited

Can a Mississippi resident get peptides by telehealth?

The Mississippi State Board of Medical Licensure regulates telemedicine in Title 30, Part 2635, Chapter 5 of the Mississippi Administrative Code. A provider (a physician or physician assistant with an unrestricted Mississippi license) must establish a valid physician-patient relationship under Rule 5.4, which includes verifying identity, taking an appropriate history and examination, and reaching a diagnosis. Rule 5.1 defines telemedicine to include store-and-forward technology, but requires technology capable of replicating a traditional in-person encounter. Rule 5.5 requires an appropriate examination before diagnosis and treatment, which need not be in person if the technology gives the physician the same information as a face-to-face exam. Rule 5.5 then says store-and-forward technology may be used to enhance, but never replace, real-time provider-patient interaction, which may be audio-visual or audio only where medically appropriate, and that a simple questionnaire without an appropriate exam violates the rule and may lead to discipline. None of the peptides in this database are controlled substances. This record classifies asynchronous prescribing as not allowed because the Board's rule requires a real-time interaction and expressly bars relying on store-and-forward or a questionnaire in its place. [2] [3] [4] [5]

How does the Mississippi pharmacy board treat compounding?

Compounding regulator for Mississippi
BoardMississippi Board of Pharmacy
Eligible substancesFollows the federal 503A framework

The Mississippi Board of Pharmacy regulates pharmacies under the Mississippi Pharmacy Practice Act (Miss. Code sections 73-21-69 to 73-21-129) and the Mississippi Pharmacy Practice Regulations (Title 30, Part 3001), including Article VI on pharmacy permits. Under section 73-21-106, any pharmacy outside Mississippi that ships, mails, or delivers prescription drugs to Mississippi residents must hold a nonresident permit, submit its latest home-state inspection report, and designate a pharmacist-in-charge who holds a Mississippi pharmacist license as well as a home-state license. The Board has published guidance on semaglutide compounding stating that semaglutide salt forms (such as semaglutide sodium or acetate) do not meet federal requirements because they are not the active ingredient in the approved product. Mississippi has no state bulks list; peptide eligibility follows the federal 503A framework. Section 73-21-106 was reenacted and amended by House Bill 856 of the 2025 Regular Session (section 18), effective on passage, and the same act moved the Pharmacy Practice Act repealer to July 1, 2029 ("Sections 73-21-71 through 73-21-129 ... shall stand repealed on July 1, 2029"), so the nonresident permit requirement is in force as of this record's check on 2026-09-22 and stays in force unless the Legislature lets the Act lapse on that date. [1] [6] [7] [8] [9] [10]

Can you get compounded GLP-1s in Mississippi?

Regulatory: Compounded GLP-1 limited

A telehealth GLP-1 program must use a physician or physician assistant with an unrestricted Mississippi license and a pharmacy holding a Mississippi permit or nonresident permit. The Board of Medical Licensure's telemedicine rule requires a real-time interaction with the provider, so a questionnaire alone does not support a prescription. [3] [5] [6] [9] [13]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Mississippi?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Mississippi

What you'll actually find in Mississippi, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [18] [19] [20]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [21]

In Mississippi, there is no legitimate prescriber route for a peptide that is not FDA approved: licensed providers may not prescribe or supply one, and a patient who gets one on their own carries the risk alone. [15]

What Mississippi has done

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [15]

Other states have acted:

  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [23] [24] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Mississippi. Expect a live video or phone visit; prescribing without one is not permitted. State law says an online questionnaire alone is not enough. [2] [3] [4] [5] That covers FDA approved peptides; for any other peptide, the boards' statement above applies. The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Mississippi Board of Pharmacy; its license search: Mississippi Board of Pharmacy license verification. [22]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [21]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [11] [25] [26]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [27] [28] [29]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [20] [29] [30]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [21] [31] [32] [33] [34] [35]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [21]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [27]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [20]
  • Pharmacy: Is this made for me on a prescription written in my name? [30]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [20] [29]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [20]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Mississippi?

The Mississippi Pharmacy Practice Act limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so sellers of "research use only" injectable peptides to Mississippi consumers are not lawful dispensers in the state. On August 19, 2026 the Mississippi State Board of Medical Licensure, Board of Nursing, and Board of Pharmacy issued a joint statement that no healthcare provider may compound, administer, dispense, prescribe, advise on, recommend, or supply a non-FDA-approved or research-grade peptide, or delegate those acts to another provider. The boards said a patient consent form calling a product research grade does not remove the provider's professional or legal liability, and providers must buy all prescription products, drugs, and ingredients from entities permitted by the Mississippi Board of Pharmacy. [1] [6] [8] [14] [15]

Peptide-specific notes for Mississippi

Peptide-specific notes for Mississippi
PeptideNote
SemaglutideAvailable branded by prescription from a physician or physician assistant with an unrestricted Mississippi license, including by telemedicine with a real-time interaction (audio-visual, or audio only where medically appropriate) under Board Rule 5.5; a questionnaire alone is not enough. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025, and the Mississippi Board of Pharmacy has said salt forms such as semaglutide sodium or acetate may not be used. [5] [9] [13]

Frequently asked questions

Can I get a GLP-1 prescription in Mississippi through telemedicine?

Yes, from a physician with a Mississippi license who establishes a valid physician-patient relationship under the Board of Medical Licensure's telemedicine rule. The rule requires a real-time interaction, by audio and video or by audio only where medically appropriate, and says a simple questionnaire without an appropriate exam violates it. Semaglutide and tirzepatide are not controlled substances. [3] [4] [5]

Can an out-of-state telehealth doctor treat me in Mississippi?

Only if the physician holds an unrestricted Mississippi license. The Board's telemedicine rule limits telemedicine with Mississippi patients to Mississippi licensees. [2] [3]

Can an out-of-state pharmacy ship compounded peptides to me in Mississippi?

Only with a Mississippi nonresident permit under Miss. Code section 73-21-106. The pharmacy must also name a pharmacist-in-charge licensed in both Mississippi and its home state. Check the Board of Pharmacy license lookup before ordering. [1] [6]

Is compounded semaglutide still available in Mississippi?

Only in limited, patient specific cases after the federal shortage allowances ended in 2025, and never from semaglutide salt forms, which the Mississippi Board of Pharmacy has said do not meet federal requirements. [9] [13]

Can a Mississippi pharmacy compound BPC-157?

Not under Mississippi's current board statement, even though a draft federal policy sets strict conditions under which HHS will not take federal enforcement action. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Mississippi has no state bulks list, and on August 19, 2026 the Mississippi State Board of Medical Licensure, Board of Nursing, and Board of Pharmacy issued a joint statement that no healthcare provider may compound, administer, dispense, prescribe, advise on, recommend, or supply a non-FDA-approved or research-grade peptide. That state limit still applies. [10] [11] [12] [15] [16] [17]

From the blog

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Mississippi Board of Pharmacy
  2. [2]Mississippi State Board of Medical Licensure: administrative code (June 2025 compilation)
  3. [3]Miss. Admin. Code Title 30, Part 2635, Chapter 5, Practice of telemedicine (rule 5.1 definitions)
  4. [4]Miss. Admin. Code Title 30, Part 2635, Rule 5.4, Physician patient relationship
  5. [5]Miss. Admin. Code Title 30, Part 2635, Rule 5.5, Examination
  6. [6]Miss. Code section 73-21-106, Registration requirement for nonresident pharmacies
  7. [7]Mississippi House Bill 856, 2025 Regular Session (as sent to Governor): reenacts section 73-21-106 and extends the Pharmacy Practice Act repealer to July 1, 2029
  8. [8]Mississippi Pharmacy Practice Regulations (Title 30, Part 3001)
  9. [9]Mississippi Board of Pharmacy: semaglutide compounding guidance
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Mississippi?. https://peptideagent.ai/legal/mississippi
HTML link
<a href="https://peptideagent.ai/legal/mississippi">Are peptides legal in Mississippi?</a>, PeptideAgent, updated October 28, 2026.